Positronen-Emissions-Tomographie - Test2 - elhamkhani - TriplyDB

Positronen-Emissions-Tomographie

Positronen-Emissions-Tomographie

http://www.wikidata.org/entity/Q55951082

about

Positronen-Emissions-Tomographie

http://www.wikidata.org/entity/Q55951082

description

im April 2012 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у квітні 2012

@uk

name

Positronen-Emissions-Tomographie

@en

Positronen-Emissions-Tomographie

@nl

type

label

Positronen-Emissions-Tomographie

@en

Positronen-Emissions-Tomographie

@nl

prefLabel

Positronen-Emissions-Tomographie

@en

Positronen-Emissions-Tomographie

@nl

P1433

Q55951082-83666D41-7AA4-4184-ABFA-6345247380C8

P1476

Q55951082-ADFD1FB3-A05F-4945-BD47-5B7ACFEC4688

P2093

Q55951082-A78667E9-8BB8-4BF1-B887-B13735C2747B

Q55951082-CC28FA4B-8687-488A-9273-1A1B815114C1

P2860

Q55951082-003846B5-8A47-4D65-A008-708BCCB3BA0C

Q55951082-04D97E64-AD73-4C5A-94E7-872291CDD018

Q55951082-050042F4-E956-458A-BD74-509C01478957

Q55951082-069ABBB6-DED4-42D2-91DD-F4263D687D85

Q55951082-09F66A1C-0DB9-4EF2-967E-ED59E60C96FC

Q55951082-0BF9E66A-151A-4AEA-A2EA-8AF282BA5E62

Q55951082-10B889CA-3C7A-4E3C-9EDA-57903AB811B9

Q55951082-272C032A-0ADE-46CD-B158-C480A9EFF685

Q55951082-2D4DA642-2BAB-4576-86C3-D7C60098BB9D

Q55951082-3773594F-90D2-49E0-8C94-591A57708FB7

P304

Q55951082-6E2A3B9B-C04E-4703-8047-8D18E5E62F01

P31

Q55951082-3F9CD617-9D66-4DB7-B326-4EC7D3570970

P356

Q55951082-ACE58B2E-AA13-44AA-BEA9-4E129CEB6C35

P433

Q55951082-9A5F01F4-55A0-4FC3-8237-DE2A9B3FAE21

P478

Q55951082-A985494C-8180-422A-BAA5-423AFBC28111

P577

Q55951082-7D07704D-C2A9-4C57-996E-E88B12840A7F

P356

P1433

Chemie in unserer Zeit

P1476

Positronen-Emissions-Tomographie

@en

P2093

Lutz Lehmann

http://www.w3.org/2001/XMLSchema#string

Marcus Bauser

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation.

Organofluorosilanes as model compounds for 18F-labeled silicon-based PET tracers and their hydrolytic stability: experimental data and theoretical calculations (PET = positron emission tomography).

Cardiac positron emission tomography.

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

PET imaging of cellular proliferation.

O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications.

Increased lipogenesis in cancer cells: new players, novel targets.

Radioligand development for PET imaging of beta-amyloid (Abeta)--current status.

Nuclear imaging probes: from bench to bedside.

P304

80-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CIUZ.201200564

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime